Lexaria Bioscience Corp.
LEXX · NASDAQ
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,802 | $6,500 | $1,352 | $5,813 |
| Short-Term Investments | $143 | $56 | $126 | $347 |
| Receivables | $368 | $154 | $175 | $202 |
| Inventory | $0 | $0 | $0 | $38 |
| Other Curr. Assets | $1,155 | $1,188 | $547 | $577 |
| Total Curr. Assets | $3,468 | $7,898 | $2,200 | $6,978 |
| Property Plant & Equip (Net) | $415 | $390 | $422 | $368 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $517 | $463 | $488 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $292 | $64 | $0 | $0 |
| Total NC Assets | $707 | $970 | $884 | $856 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,175 | $8,868 | $3,084 | $7,834 |
| Liabilities | – | – | – | – |
| Payables | $0 | $371 | $225 | $26 |
| Short-Term Debt | $30 | $28 | $28 | $85 |
| Tax Payable | $0 | $9 | $15 | $31 |
| Deferred Revenue | $0 | $5 | $0 | $0 |
| Other Curr. Liab. | $1,463 | $687 | $0 | $52 |
| Total Curr. Liab. | $1,493 | $1,099 | $268 | $194 |
| LT Debt | $79 | $109 | $136 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $79 | $109 | $136 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $137 | $164 | $50 |
| Total Liabilities | $1,572 | $1,209 | $404 | $201 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $16 | $8 | $6 |
| Retained Earnings | -$63,461 | -$51,559 | -$45,763 | -$39,099 |
| AOCI | -$70 | -$20 | $0 | $0 |
| Other Equity | $66,521 | $59,599 | $48,799 | $47,041 |
| Total Equity | $2,990 | $8,036 | $3,044 | $7,949 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$387 | -$377 | -$364 | -$316 |
| Total Liab. & Tot. Equity | $4,175 | $8,868 | $3,084 | $7,834 |
| Net Debt | -$1,693 | -$6,363 | -$1,188 | -$5,721 |